Cerit Ethem Turgay, Cerit Mahinur
Ankara Memorial Hospital, Endocrinology and Metabolism Department, Ankara, Turkey.
Gazi University Faculty of Medicine, Radiology Department, Ankara, Turkey.
Bone Rep. 2020 Aug 13;13:100706. doi: 10.1016/j.bonr.2020.100706. eCollection 2020 Dec.
Pregnancy and lactation associated osteoporosis (PLO) is a rare condition that may present with fragility fractures occurring for the first time in pregnancy or postpartum period while breastfeeding. Here, we report a rare case of PLO in the 3rd pregnancy treated with teriparatide.
A 35-year-old woman who presented with back pain (visual analogue scale; VAS = 10/10) two months after her third delivery. PLO was diagnosed from multiple vertebral fragility fractures and low bone mineral density (BMD). She was treated with teriparatide and her pain significantly reduced in the second month. After 12 months of teriparatide treatment, her BMD increased 18.1% from the baseline.
PLO should be considered in patients who complain with back pain during late pregnancy and postpartum period. Weaning off breastfeeding and supplementation of calcium/vitamin D should be the first recommendation as conventional treatment after the diagnosis of PLO. Teriparatide may be an effective option to improve the recovery of BMD If there is not enough improvement with conventional treatment.
妊娠和哺乳期相关骨质疏松症(PLO)是一种罕见病症,可能表现为在孕期或哺乳期首次发生的脆性骨折。在此,我们报告一例在第三次妊娠时使用特立帕肽治疗的罕见PLO病例。
一名35岁女性在第三次分娩后两个月出现背痛(视觉模拟评分法;VAS = 10/10)。通过多处椎体脆性骨折和低骨密度(BMD)诊断为PLO。她接受了特立帕肽治疗,第二个月疼痛明显减轻。经过12个月的特立帕肽治疗,她的骨密度较基线增加了18.1%。
对于在妊娠晚期和产后出现背痛的患者应考虑PLO。断奶和补充钙/维生素D应作为PLO诊断后常规治疗的首要建议。如果常规治疗改善不足,特立帕肽可能是改善骨密度恢复的有效选择。